12.19
price up icon1.08%   0.13
after-market Handel nachbörslich: 12.30 0.11 +0.90%
loading
Schlusskurs vom Vortag:
$12.06
Offen:
$12.1
24-Stunden-Volumen:
1.03M
Relative Volume:
0.57
Marktkapitalisierung:
$1.28B
Einnahmen:
$17.49M
Nettoeinkommen (Verlust:
$-78.50M
KGV:
-10.16
EPS:
-1.2
Netto-Cashflow:
$-52.85M
1W Leistung:
-4.99%
1M Leistung:
-26.26%
6M Leistung:
-0.81%
1J Leistung:
+1.92%
1-Tages-Spanne:
Value
$11.89
$12.30
1-Wochen-Bereich:
Value
$11.85
$13.37
52-Wochen-Spanne:
Value
$8.26
$19.41

Liquidia Corp Stock (LQDA) Company Profile

Name
Firmenname
Liquidia Corp
Name
Telefon
919.328.4400
Name
Adresse
419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC
Name
Mitarbeiter
170
Name
Twitter
@Liquidia_Inc
Name
Nächster Verdiensttermin
2025-03-19
Name
Neueste SEC-Einreichungen
Name
LQDA's Discussions on Twitter

Vergleichen Sie LQDA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
LQDA
Liquidia Corp
12.19 1.28B 17.49M -78.50M -52.85M -1.20
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
459.62 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.36 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
331.91 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
543.48 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.49 28.51B 3.81B -644.79M -669.77M -6.24

Liquidia Corp Stock (LQDA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-05-19 Herabstufung Oppenheimer Perform → Underperform
2024-12-20 Eingeleitet Wells Fargo Overweight
2024-10-16 Eingeleitet Scotiabank Sector Outperform
2024-08-19 Hochstufung Raymond James Outperform → Strong Buy
2024-08-16 Eingeleitet Raymond James Outperform
2024-06-25 Eingeleitet Oppenheimer Perform
2024-01-05 Bestätigt Needham Buy
2022-09-19 Fortgesetzt Wedbush Underperform
2022-09-01 Herabstufung Wedbush Neutral → Underperform
2022-07-22 Eingeleitet Ladenburg Thalmann Buy
2022-05-31 Eingeleitet BTIG Research Buy
2022-05-26 Eingeleitet BofA Securities Buy
2020-12-04 Eingeleitet H.C. Wainwright Buy
2020-11-20 Herabstufung Wedbush Outperform → Neutral
2018-11-08 Fortgesetzt Jefferies Buy
2018-09-05 Eingeleitet Wedbush Outperform
2018-08-20 Eingeleitet Jefferies Buy
2018-08-20 Eingeleitet Needham Buy
Alle ansehen

Liquidia Corp Aktie (LQDA) Neueste Nachrichten

pulisher
Jun 12, 2025

Wells Fargo Raises Price Target for Liquidia (LQDA) to $25 | LQD - GuruFocus

Jun 12, 2025
pulisher
Jun 11, 2025

Liquidia (LQDA): B of A Securities Lowers Price Target to $23 | LQDA Stock News - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

# Raymond James reiterates Strong Buy on Liquidia stock amid competition - Investing.com

Jun 11, 2025
pulisher
Jun 11, 2025

Liquidia (LQDA) Sees Surge in Options Activity Ahead of Earnings - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

# Raymond James reiterates Strong Buy on Liquidia stock amid competition By Investing.com - Investing.com UK

Jun 11, 2025
pulisher
Jun 10, 2025

Biotech Hits A 'Home Run' And Slams Its Two Key Rivals - Investor's Business Daily

Jun 10, 2025
pulisher
Jun 10, 2025

Liquidia (LQDA) Sees Surge in Options Activity Ahead of Earnings | LQDA Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 06, 2025

Treprostinil Saga Continues - JD Supra

Jun 06, 2025
pulisher
Jun 04, 2025

Liquidia at Jefferies Conference: Strategic Moves in PAH Market - Investing.com

Jun 04, 2025
pulisher
Jun 03, 2025

BTIG Raises Liquidia Price Target Following YUTREPIA Approval - Insider Monkey

Jun 03, 2025
pulisher
Jun 02, 2025

Judge Denies UTC Bid To Block Liquidia's Lung Drug - Law360

Jun 02, 2025
pulisher
Jun 02, 2025

Liquidia (LQDA) Stock Price Target Raised by Analyst | LQDA Stoc - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Raymond James maintains strong buy on Liquidia stock following court ruling By Investing.com - Investing.com South Africa

Jun 02, 2025
pulisher
Jun 02, 2025

BTIG raises Liquidia stock price target following FDA approval By Investing.com - Investing.com South Africa

Jun 02, 2025
pulisher
Jun 02, 2025

Raymond James maintains strong buy on Liquidia stock following court ruling - Investing.com India

Jun 02, 2025
pulisher
Jun 02, 2025

BTIG raises Liquidia stock price target following FDA approval - Investing.com

Jun 02, 2025
pulisher
Jun 02, 2025

Liquidia Beats UTC Bid to Block Launch of Lung Drug Yutrepia - Bloomberg Law News

Jun 02, 2025
pulisher
Jun 02, 2025

Liquidia stock rises following YUTREPIA shipment news By Investing.com - Investing.com Canada

Jun 02, 2025
pulisher
Jun 02, 2025

Liquidia stock rises following YUTREPIA shipment news - Investing.com

Jun 02, 2025
pulisher
Jun 02, 2025

Needham raises Liquidia Technologies stock price target after court ruling By Investing.com - Investing.com South Africa

Jun 02, 2025
pulisher
Jun 02, 2025

Needham raises Liquidia Technologies stock price target after court ruling - Investing.com

Jun 02, 2025
pulisher
Jun 02, 2025

Liquidia (LQDA) Gets Price Target Boost from Needham | LQDA Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Liquidia Set to Make First Commercial Shipment of Yutrepia for Pulmonary Hypertension - marketscreener.com

Jun 02, 2025
pulisher
Jun 02, 2025

Liquidia starts commercial shipment of FDA-approved YUTREPIA By Investing.com - Investing.com India

Jun 02, 2025
pulisher
Jun 02, 2025

Liquidia (LQDA) Begins Commercial Launch of YUTREPIA Following L - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Liquidia (LQDA) Begins Commercial Launch of YUTREPIA Following Legal Victory | LQDA Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Liquidia starts commercial shipment of FDA-approved YUTREPIA - Investing.com

Jun 02, 2025
pulisher
Jun 02, 2025

Liquidia Schedules First Commercial Shipment of YUTREPIA™ (treprostinil) Inhalation Powder for Patients with PAH and PH-ILD - The Manila Times

Jun 02, 2025
pulisher
Jun 02, 2025

BTIG reaffirms buy rating for Liquidia stock amid legal developments By Investing.com - Investing.com South Africa

Jun 02, 2025
pulisher
Jun 02, 2025

Gold Is Bullish, But Be Aware Of Deeper Intraday Pullback; Elliott Wave Intraday Analysis - The Globe and Mail

Jun 02, 2025
pulisher
Jun 02, 2025

BTIG reaffirms buy rating for Liquidia stock amid legal developments - Investing.com

Jun 02, 2025
pulisher
May 31, 2025

Liquidia Corporation Reports First Quarter 2025 Financial Results and Provides Corporate Update - mx.advfn.com

May 31, 2025
pulisher
May 29, 2025

Liquidia Told to Swap Two Defenses Ahead of Trial on UTC Patent - Bloomberg Law News

May 29, 2025
pulisher
May 29, 2025

Liquidia (NASDAQ:LQDA) Given New $23.00 Price Target at Wells Fargo & Company - Defense World

May 29, 2025
pulisher
May 29, 2025

Wells Fargo lifts Liquidia stock price target to $23 from $20 By Investing.com - Investing.com South Africa

May 29, 2025
pulisher
May 29, 2025

H.C. Wainwright lifts Liquidia stock target to $35 on FDA nod By Investing.com - Investing.com South Africa

May 29, 2025
pulisher
May 29, 2025

Liquidia (NASDAQ:LQDA) Given New $35.00 Price Target at HC Wainwright - Defense World

May 29, 2025
pulisher
May 28, 2025

Scotiabank Raises Price Target for Liquidia (LQDA) to $37.00 | LQDA Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

These Analysts Boost Their Forecasts On Liquidia - Benzinga

May 28, 2025
pulisher
May 28, 2025

Scotiabank Increases Price Target for Liquidia (LQDA) After Yutrepia Approval | LQDA Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Liquidia (LQDA) Sees Target Price Increased by Wells Fargo Analy - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Liquidia (LQDA) Sees Target Price Increased by Wells Fargo Analyst | LQDA Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Liquidia Technologies stock target raised to $33 at Raymond James - Investing.com

May 28, 2025
pulisher
May 28, 2025

Breaking Down Liquidia: 12 Analysts Share Their ViewsLiquidia (NASDAQ:LQDA) - Benzinga

May 28, 2025
pulisher
May 28, 2025

Liquidia (LQDA) Price Target Raised to $35 by HC Wainwright | LQ - GuruFocus

May 28, 2025
pulisher
May 28, 2025

H.C. Wainwright lifts Liquidia stock target to $35 on FDA nod - Investing.com

May 28, 2025
pulisher
May 28, 2025

Liquidia (LQDA) Target Price Boosted Following FDA Approval | LQ - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Scotiabank raises Liquidia stock target to $37 on Yutrepia™ launch By Investing.com - Investing.com South Africa

May 28, 2025
pulisher
May 28, 2025

Scotiabank raises Liquidia stock target to $37 on Yutrepia™ launch - Investing.com

May 28, 2025
pulisher
May 28, 2025

Liquidia (LQDA) Target Price Boosted Following FDA Approval | LQDA Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Liquidia Corporation to Present at the 2025 Jefferies Global Healthcare Conference - Yahoo Finance

May 28, 2025

Finanzdaten der Liquidia Corp-Aktie (LQDA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Liquidia Corp-Aktie (LQDA) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Moomaw Scott
Chief Commercial Officer
Jun 04 '25
Sale
16.97
6,656
112,952
224,921
Saggar Rajeev
Chief Medical Officer
Jun 04 '25
Sale
16.97
7,597
128,921
273,209
JEFFS ROGER
Chief Executive Officer
Jun 04 '25
Sale
16.97
30,610
519,452
1,044,979
Kaseta Michael
CFO and COO
Jun 04 '25
Sale
16.97
14,777
250,766
412,164
Adair Jason
Chief Business Officer
Jun 04 '25
Sale
16.97
3,597
61,041
193,735
Schundler Russell
General Counsel
Jun 02 '25
Sale
16.74
923
15,451
571,722
Moomaw Scott
Chief Commercial Officer
Jun 02 '25
Sale
16.74
581
9,726
216,038
Kaseta Michael
CFO and COO
Jun 02 '25
Sale
16.74
859
14,380
397,800
Adair Jason
Chief Business Officer
Jun 02 '25
Sale
16.74
451
7,550
184,961
Adair Jason
Chief Business Officer
Apr 28 '25
Sale
14.24
455
6,479
183,849
$20.30
price down icon 0.68%
$36.37
price up icon 0.50%
$24.55
price up icon 8.53%
$97.80
price down icon 0.45%
$110.00
price up icon 1.61%
biotechnology ONC
$245.49
price up icon 0.48%
Kapitalisierung:     |  Volumen (24h):